Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017 Deaths Force Merck & Co. to Halt Enrollment for Blood Cancer Studies June 12, 2017
BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017